Sign in

CIK 0001533998

  • Non-accelerated filer
  • Smaller reporting company

DarioHealth Corp.

Sign in to watch
Ticker
DRIO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
452973162
Phone
+972 47706377
Business address
322 W 57TH ST. #33B, NEW YORK, NY, 10019
Former names
LabStyle Innovations Corp.
  1. 4 Open-market buy President and CCO bought 40,000 shares at $0.53 ($21,200)
  2. 4 Grant or award Chief Financial Officer acquired 500,000 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 30,000 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $0.91 ($4,546)
  8. 4 Open-market buy Chief Commercial Officer bought 10,000 shares at an average $0.82 ($8,244)
  9. 4 Open-market buy Chief Commercial Officer bought 15,000 shares at an average $0.82 ($12,292)
  10. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $0.88 ($4,400)
  11. 4 Open-market buy Chief Commercial Officer bought 15,000 shares at an average $0.94 ($14,147)
  12. 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $0.94 ($9,400)
  13. 4 Open-market buy Chief Commercial Officer bought 10,000 shares at an average $0.93 ($9,283)
  14. 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $0.90 ($8,980)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Chief Financial Officer acquired 400,000 shares (grant or award)
  18. 4 Grant or award Director acquired 90,000 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Director acquired 70,000 shares (grant or award)

Page 2 of 20 · 387 filings